Search research articles
Contact Us
Filters
Showing results (201-210 of 634) with videos related to
Page
of 64
Sort By:
BMB Reports
|
November 20, 2024
Recombinant ADAMTS1 promotes muscle cell differentiation and alleviates muscle atrophy by repressing NOTCH1
Sang Hyup Lee, Sang Yoon Kim, Yun Gu Gwon, et al.
Experimental & Molecular Medicine
|
March 23, 2021
High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer
Jeong Eun Kim, Jaeyong Choi, Chang-Ohk Sung, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 17, 2010
Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia
Shin Ahn, Yoon-Seon Lee, Yun-Hee Chun, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
July 15, 2025
Associations between Diabetes, Diabetes Duration, and Psychiatric Difficulties: A Nationwide Cross-sectional Study
Young-Chan Kim, Kyungdo Han, Suhyung Kim, et al.
Psychiatry Investigation
|
August 19, 2024
Obstructive Sleep Apnea and Medical Comorbidities in the Asian Population: Evidence From a Nationwide Healthcare System Data in South Korea
Minbi Lee, Jihye Oh, Yoo Hyun Um, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 8, 2016
Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer
Timothy Price, Tae Won Kim, Jin Li, et al.
Toxicologic Pathology
|
November 5, 2008
Nonclinical safety evaluation of sunitinib: a potent inhibitor of VEGF, PDGF, KIT, FLT3, and RET receptors
Shem Patyna, Claudio Arrigoni, Andrea Terron, et al.
Oncoimmunology
|
December 1, 2022
Comprehensive evaluation of the tumor immune microenvironment and its dynamic changes in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy: From the phase II ADORE study
Hyungwoo Cho, Jeong Eun Kim, Yong Sang Hong, et al.
Anticancer Research
|
January 18, 2003
Oral mucosal carcinogenesis in SENCAR mice
Tae-Won Kim, Qianming Chen, Xiaodong Shen, et al.
Cancer Genetics
|
July 27, 2021
Longitudinal change of genetic variations in cetuximab-treated metastatic colorectal cancer
Sun Young Kim, Kwoneel Kim, Su Han Cho, et al.
Page
of 64
Search research articles
Search
Showing results (201-210 of 634) with videos related to
Sort By:
Page
of 64
BMB Reports
|
November 20, 2024
Recombinant ADAMTS1 promotes muscle cell differentiation and alleviates muscle atrophy by repressing NOTCH1
Sang Hyup Lee, Sang Yoon Kim, Yun Gu Gwon, et al.
Experimental & Molecular Medicine
|
March 23, 2021
High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer
Jeong Eun Kim, Jaeyong Choi, Chang-Ohk Sung, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 17, 2010
Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia
Shin Ahn, Yoon-Seon Lee, Yun-Hee Chun, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
July 15, 2025
Associations between Diabetes, Diabetes Duration, and Psychiatric Difficulties: A Nationwide Cross-sectional Study
Young-Chan Kim, Kyungdo Han, Suhyung Kim, et al.
Psychiatry Investigation
|
August 19, 2024
Obstructive Sleep Apnea and Medical Comorbidities in the Asian Population: Evidence From a Nationwide Healthcare System Data in South Korea
Minbi Lee, Jihye Oh, Yoo Hyun Um, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 8, 2016
Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer
Timothy Price, Tae Won Kim, Jin Li, et al.
Toxicologic Pathology
|
November 5, 2008
Nonclinical safety evaluation of sunitinib: a potent inhibitor of VEGF, PDGF, KIT, FLT3, and RET receptors
Shem Patyna, Claudio Arrigoni, Andrea Terron, et al.
Oncoimmunology
|
December 1, 2022
Comprehensive evaluation of the tumor immune microenvironment and its dynamic changes in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy: From the phase II ADORE study
Hyungwoo Cho, Jeong Eun Kim, Yong Sang Hong, et al.
Anticancer Research
|
January 18, 2003
Oral mucosal carcinogenesis in SENCAR mice
Tae-Won Kim, Qianming Chen, Xiaodong Shen, et al.
Cancer Genetics
|
July 27, 2021
Longitudinal change of genetic variations in cetuximab-treated metastatic colorectal cancer
Sun Young Kim, Kwoneel Kim, Su Han Cho, et al.
Page
of 64